These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19305698)

  • 1. Income-based drug coverage in British Columbia: the impact on the distribution of financial burden.
    Hanley GE; Morgan S; Yan L
    Healthc Policy; 2006 Nov; 2(2):e170-86. PubMed ID: 19305698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.
    Hanley GE; Morgan S; Hurley J; van Doorslaer E
    Health Econ; 2008 Dec; 17(12):1379-92. PubMed ID: 18189226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Income-based drug coverage in British Columbia: the impact on private and public expenditures.
    Morgan S; Yan L
    Healthc Policy; 2006 Nov; 2(2):e129-53. PubMed ID: 19305696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Income-Based Drug Coverage in British Columbia: Lessons for BC and the Rest of Canada.
    Morgan S; Evans RG; Hanley GE; Caetano PA; Black C
    Healthc Policy; 2006 Nov; 2(2):115-27. PubMed ID: 19305708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The redistributive effect of the move from age-based to income-based prescription drug coverage in British Columbia, Canada.
    Hanley GE; Morgan S; Barer M; Reid RJ
    Health Policy; 2011 Jul; 101(2):185-94. PubMed ID: 21255859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Income-based drug coverage in british columbia: towards an understanding of the policy.
    Morgan S; Coombes M
    Healthc Policy; 2006 Nov; 2(2):92-108. PubMed ID: 19305707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a household-level deductible on prescription drug use among lower-income adults: a quasi-experimental study.
    Law MR; Cheng L; Worthington H; Majumdar SR; McGrail KM; Chan F; Laba TL; Mamdani M
    CMAJ Open; 2019; 7(1):E167-E173. PubMed ID: 30926600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who's the fairest of them all? Which provincial pharmacare model would best protect Canadians against catastrophic drug costs?
    Coombes ME; Morgan SG; Barer ML; Pagliccia N
    Healthc Q; 2004; 7(4):suppl 13-9. PubMed ID: 15540402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Income-based drug coverage in British Columbia: the impact on access to medicines.
    Caetano PA; Raymond CB; Morgan S; Yan L
    Healthc Policy; 2006 Nov; 2(2):e154-69. PubMed ID: 19305697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2012 Aug; 18(4 Suppl 4):1-23. PubMed ID: 22947491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hong Kong domestic health spending: financial years 1989/90 to 2009/10.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2013 Apr; 19(2 Suppl 3):1-24. PubMed ID: 23589588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth in private payments for health care by Canadian households.
    Law MR; Daw JR; Cheng L; Morgan SG
    Health Policy; 2013 May; 110(2-3):141-6. PubMed ID: 23419418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equity in health financing of Guangxi after China's universal health coverage: evidence based on health expenditure comparison in rural Guangxi Zhuang autonomous region from 2009 to 2013.
    Qin X; Luo H; Feng J; Li Y; Wei B; Feng Q
    Int J Equity Health; 2017 Sep; 16(1):174. PubMed ID: 28962656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hong Kong domestic health spending: financial years 1989/90 to 2011/12.
    Tin KY; Tsoi PK; Lee YH; Chong DS; Lam DW; Yeung AY; Ma ES; Maw CK
    Hong Kong Med J; 2015 Jun; 21(3 Suppl 3):1-24. PubMed ID: 26045183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financing incidence analysis of household out-of-pocket spending for healthcare: getting more health for money in Nigeria?
    Onwujekwe O; Hanson K; Ichoku H; Uzochukwu B
    Int J Health Plann Manage; 2014; 29(2):e174-85. PubMed ID: 23390079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hong Kong domestic health spending: financial years 1989/90 to 2010/11.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Yeung AY; Chui AW; Tay MS
    Hong Kong Med J; 2013 Dec; 19(6 Suppl 7):1-24. PubMed ID: 24356244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing progressivity and catastrophic effect of out-of-pocket payments for healthcare in Canada: 2010-2015.
    Edmonds S; Hajizadeh M
    Eur J Health Econ; 2019 Sep; 20(7):1001-1011. PubMed ID: 31140059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of equity in Brazilian health system financing.
    Ugá MA; Santos IS
    Health Aff (Millwood); 2007; 26(4):1017-28. PubMed ID: 17630445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of income-based deductibles on drug use and health care utilization among older adults.
    Law MR; Cheng L; Worthington H; Mamdani M; McGrail KM; Chan FKI; Majumdar SR
    CMAJ; 2017 May; 189(19):E690-E696. PubMed ID: 28507088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in out-of-pocket payments for healthcare in Vietnam and its impact on equity in payments, 1992-2002.
    Chaudhuri A; Roy K
    Health Policy; 2008 Oct; 88(1):38-48. PubMed ID: 18423775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.